KeyBanc analyst issues OVERWEIGHT recommendation for META on February 2, 2024 05:46AM ET. The previous analyst recommendation was Overweight.META was trading at $394.78 at issue of the analyst recommendation.The overall...
UBS analyst issues BUY recommendation for XOM on February 2, 2024 02:10AM ET. The previous analyst recommendation was Buy.XOM was trading at $102.39 at issue of the analyst recommendation.The overall...
BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the analyst recommendation.The...
Scotiabank analyst issues PERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Sector Outperform.CVX was trading at $147.89 at issue of the analyst recommendation.The...
Raymond James analyst issues OUTPERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Outperform.CVX was trading at $147.89 at issue of the analyst recommendation.The...
Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the analyst recommendation.The...
Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the analyst recommendation.The...
BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the analyst recommendation.The...
BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the analyst recommendation.The...
RBC Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the analyst recommendation.The...
